Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Receivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

AIM ImmunoTech (AIM) Convertible Debt (2018 - 2019)

Historic Convertible Debt for ImmunoTech (AIM) over the last 2 years, with Q3 2019 value amounting to $2.3 million.

  • ImmunoTech's Convertible Debt fell 3247.71% to $2.3 million in Q3 2019 from the same period last year, while for Sep 2019 it was $2.3 million, marking a year-over-year decrease of 3247.71%. This contributed to the annual value of $3.4 million for FY2018, which is N/A changed from last year.
  • As of Q3 2019, ImmunoTech's Convertible Debt stood at $2.3 million, which was down 3247.71% from $2.3 million recorded in Q2 2019.
  • Over the past 5 years, ImmunoTech's Convertible Debt peaked at $3.7 million during Q1 2019, and registered a low of $2.3 million during Q2 2019.